Cargando…

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine

BACKGROUND: Bladder urothelial carcinoma (BLCA) is associated with high mortality and recurrence. Although mRNA-based vaccines are promising treatment strategies for combating multiple solid cancers, their efficacy against BLCA remains unclear. We aimed to identify potential effective antigens of BL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhuolun, Jing, Changying, Zhan, Hailun, Guo, Xudong, Suo, Ning, Kong, Feng, Tao, Wen, Xiao, Chutian, Hu, Daoyuan, Wang, Hanbo, Jiang, Shaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905425/ https://www.ncbi.nlm.nih.gov/pubmed/36761744 http://dx.doi.org/10.3389/fimmu.2023.1097472

Ejemplares similares

Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2022)

An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients
por: Sun, Zhuolun, et al.
Publicado: (2020)

Inflammatory myofibroblastic tumor of kidney together with ipsilateral perinephric and periureteric fibrosis: A case report and literature review
por: Sun, Zhuolun, et al.
Publicado: (2017)

Comprehensive Analysis of the Immune Infiltrates of Pyroptosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2021)

Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2020)

Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2020)

Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma
por: Guo, Xudong, et al.
Publicado: (2021)

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2022)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer
por: van Dijk, Nick, et al.
Publicado: (2021)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development
por: Wang, Guixin, et al.
Publicado: (2022)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
por: Ladak, Reese Jalal, et al.
Publicado: (2022)

Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile
por: Peng, Mou
Publicado: (2022)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
por: Lin, Han, et al.
Publicado: (2022)

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
por: Li, Tianhang, et al.
Publicado: (2022)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder
por: Yang, Meihua, et al.
Publicado: (2022)

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder
por: Feng, Huan, et al.
Publicado: (2023)

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
por: Tang, Qi, et al.
Publicado: (2023)

Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer
por: Daza-Cajigal, Vanessa, et al.
Publicado: (2019)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent
por: Kong, Jianqiu, et al.
Publicado: (2022)

Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
por: Loomis, Rebecca J., et al.
Publicado: (2021)

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022)

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer
por: Xu, Chao, et al.
Publicado: (2023)

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
por: Ye, Liguo, et al.
Publicado: (2021)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
por: Sikic, Danijel, et al.
Publicado: (2019)

The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy
por: Hardy, Marie-Pierre, et al.
Publicado: (2019)

Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
por: An, Bingzheng, et al.
Publicado: (2022)

Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma
por: Yan, Xin, et al.
Publicado: (2022)

An mRNA vaccine against rabies provides strong and durable protection in mice
por: Li, Miao, et al.
Publicado: (2023)

Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
por: Waghela, Ishita N., et al.
Publicado: (2022)

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection
por: Munari, Enrico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g5lmnrnnfmdllb8ijrvbundkka